Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
876
DELISTED
Exact Sciences
EXAS
| $33.5M | 0.02% |
362,434
+31,144
| +9% | +$2.74M |
|
|
PRSP
877
DELISTED
Perspecta Inc. Common Stock
PRSP
| $33.5M | 0.02% |
1,267,385
+39,664
| +3% | +$1.06M |
|
878
Enovis
ENOV
$1.4B
| $33.4M | 0.02% |
534,050
-8,338
| -2% | -$471K |
|
879
SLM Corp
SLM
$5.14B
| $33.3M | 0.02% |
3,742,213
-207,593
| -5% | -$1.8M |
|
880
Murphy Oil
MUR
$5.09B
| $33.3M | 0.02% |
1,244,128
+6,064
| +0.5% | +$139K |
|
881
Warner Bros
WBD
$67.4B
| $33.3M | 0.02% |
1,018,087
-198,683
| -16% | -$5.99M |
|
|
ROIC
882
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $33.2M | 0.02% |
1,880,683
+79,259
| +4% | +$1.43M |
|
883
Moog Inc Class A
MOG.A
$13B
| $33.2M | 0.02% |
388,905
+4,274
| +1% | +$365K |
|
884
Insperity
NSP
$1.96B
| $33.1M | 0.02% |
384,373
-3,189
| -0.8% | -$277K |
|
885
Hexcel
HXL
$7.63B
| $32.9M | 0.02% |
449,131
+6,107
| +1% | +$469K |
|
886
Hancock Whitney
HWC
$6.23B
| $32.8M | 0.02% |
748,221
-6,461
| -0.9% | -$262K |
|
|
DHC
887
Diversified Healthcare Trust
DHC
$2.04B
| $32.8M | 0.02% |
3,887,814
+159,081
| +4% | +$1.34M |
|
888
KKR & Co
KKR
$93.2B
| $32.8M | 0.02% |
1,124,004
+30,118
| +3% | +$858K |
|
889
Bath & Body Works
BBWI
$3.89B
| $32.8M | 0.02% |
2,238,220
+92,102
| +4% | +$1.33M |
|
890
Alcoa
AA
$13.6B
| $32.8M | 0.02% |
1,523,645
+22,159
| +1% | +$459K |
|
|
CDK
891
DELISTED
CDK Global, Inc.
CDK
| $32.8M | 0.02% |
598,972
+12,717
| +2% | +$653K |
|
892
AstraZeneca
AZN
$251B
| $32.7M | 0.02% |
328,250
-91,750
| -22% | -$8.64M |
|
893
Liberty Global Class C
LBTYK
$3.41B
| $32.7M | 0.02% |
1,501,384
+51,275
| +4% | +$1.15M |
|
894
Old Republic International
ORI
$10.3B
| $32.7M | 0.02% |
1,461,409
+31,303
| +2% | +$712K |
|
895
Eagle Materials
EXP
$6.47B
| $32.6M | 0.02% |
359,054
+5,752
| +2% | +$527K |
|
|
BERY
896
DELISTED
Berry Global Group, Inc.
BERY
| $32.5M | 0.02% |
746,310
-240,397
| -24% | -$9.52M |
|
897
Wintrust Financial
WTFC
$10.7B
| $32.4M | 0.02% |
457,487
+15,287
| +3% | +$1.02M |
|
898
Nexstar Media Group
NXST
$5.91B
| $32.3M | 0.02% |
275,190
+11,444
| +4% | +$1.2M |
|
|
SF
899
Stifel
SF
$12.7B
| $32.2M | 0.02% |
1,196,134
-2,943
| -0.2% | -$76.9K |
|
900
Integra LifeSciences
IART
$1.33B
| $32.1M | 0.02% |
550,934
+6,704
| +1% | +$399K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.